Allergy and Asthma Proceedings

Papers
(The H4-Index of Allergy and Asthma Proceedings is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Hereditary angioedema: Epidemiology and burden of disease62
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome45
The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?41
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-231
COVID-19 in children: Pathogenesis and current status31
Triggers and short-term prophylaxis in patients with hereditary angioedema28
Definition and classification of hereditary angioedema28
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination27
Patient perspectives on the treatment burden of injectable medication for hereditary angioedema25
Treatment strategies for postviral olfactory dysfunction: A systematic review23
COVID-19 in a patient with severe asthma using mepolizumab23
Clinical presentation of hereditary angioedema23
Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)22
Hereditary angioedema: Special considerations in women21
Hereditary angioedema: On-demand treatment of angioedema attacks20
Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation20
The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome19
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?19
Hereditary angioedema and shared decision making19
Hereditary angioedema: Differential diagnosis, diagnostic tests, and family screening19
0.023652076721191